GL1X · GenesisL1 explorer

MolNFT v1 · #186406 · protein

Non-receptor protein tyrosine phosphatase SHP2 in complex with allosteric inhibitor rmc-4550

7RCT · Tyrosine-protein phosphatase non-receptor type 11: “Non-receptor protein tyrosine phosphatase SHP2 in complex with allosteric inhibitor rmc-4550”. X-ray diffraction, 2 ligands (4Q4, CL), 14 pockets (best druggability 0.69). MolNFT…

PDB
7RCT
Type
protein
Length
991 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 11
EC
3.1.3.48
UniProt
Q06124
Ligands
4Q4, CL
Pockets
14 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BTyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein50130% helix, 26% strandQ06124
ATyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein49031% helix, 26% strandQ06124

Ligands and binding sites

  • 4Q4 · {3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl}methanol · ligand · 2 copies · chains B, A
  • CL · Chloride ion · ion · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14420.690.80394Q4
26890.660.7562empty
34160.650.78374Q4, CL
41030.520.8324empty
52430.490.7432empty

Interfaces

1 interface between chains.

  • B–A · 190 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 7RCT · Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.